Researchers from Case Comprehensive Cancer Center at Case Western Reserve University aim to increase prostate cancer in African American men with a $2.75 million, three-year grant from the Bristol Myers Squibb Foundation.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
